Edition:
United Kingdom

Baxter International Inc (BAX.N)

BAX.N on New York Stock Exchange

65.48USD
10 Dec 2018
Change (% chg)

$0.46 (+0.71%)
Prev Close
$65.02
Open
$64.99
Day's High
$65.70
Day's Low
$63.99
Volume
1,496,546
Avg. Vol
857,031
52-wk High
$78.36
52-wk Low
$61.06

Chart for

About

Baxter International Inc., through its subsidiaries, provides renal and hospital products. The Company operates through two segments: Hospital Products and Renal. Its Hospital Products business manufactures sterile intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled... (more)

Overall

Beta: 0.70
Market Cap(Mil.): $34,277.83
Shares Outstanding(Mil.): 544.87
Dividend: 0.16
Yield (%): 1.02

Financials

  BAX.N Industry Sector
P/E (TTM): 38.37 32.18 33.63
EPS (TTM): 1.64 -- --
ROI: 6.78 13.76 15.02
ROE: 10.22 16.50 16.60

Smiths and ICU Medical healthcare merger talks collapse

British engineering firm Smiths Group Plc said on Thursday talks with U.S.-based ICU Medical Inc over a possible 7 billion pound-plus merger of their healthcare businesses had fallen through.

13 Sep 2018

Smiths and ICU Medical healthcare merger talks collapse

British engineering firm Smiths Group Plc said on Thursday talks with U.S.-based ICU Medical Inc over a possible 7 billion pound-plus ($9.2 billion) merger of their healthcare businesses had fallen through.

13 Sep 2018

UPDATE 1-Smiths Group, ICU Medical close to abandoning healthcare merger -Sky News

Aug 7 British engineering firm Smiths Group Plc is close to abandoning talks with U.S.-based ICU Medical Inc over a 7 billion pound ($9 billion) merger of their healthcare divisions, Sky News reported on Monday.

07 Aug 2018

Earnings vs. Estimates